← Leaderboards
Greg Thurber
University Of Michigan At Ann Arbor
$4,032,895
Attributed
$4,646,934
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,646,934 · 4
By mechanism
R35$2,437,059 · 1
R01$1,228,078 · 1
K01$640,656 · 1
R21$341,141 · 1
Top collaborators
- Peter M Tessier2 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Lori L Isom$24,363,897
- Jack M Parent$14,873,271
- Peter M Tessier$7,601,443
- Colin Fred Greineder$2,818,848
- Miriam H Meisler$27,545,261
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelCellsMolecular ImagingPharmaceutical PreparationsImmuneDesignDoseResolutionMeasurementSuccessPropertyIn VivoUptakeAntibodiesGoldAntigensChemistryComputer SimulationImaging ApproachSmall MoleculeAnimal ModelDrug KineticsDrug TransportMetabolism
Grant awards (15)
Neuron-specific modulation of gene expression using systemically administered bispecific antibody-ASO conjugates$609,153
R01 · FY2025 · NS · contact PI
Designing Antibody Drug Conjugates for Durable and Complete Therapeutic Responses$397,428
R35 · FY2025 · GM · contact PI
Neuron-specific modulation of gene expression using systemically administered bispecific antibody-ASO conjugates$618,925
R01 · FY2024 · NS · contact PI
Designing Antibody Drug Conjugates for Durable and Complete Therapeutic Responses$398,642
R35 · FY2024 · GM · contact PI
Maximizing Antibody Drug Conjugate Efficacy through Multiple Mechanisms of Action$318,224
R35 · FY2022 · GM · contact PI
Maximizing Antibody Drug Conjugate Efficacy through Multiple Mechanisms of Action$326,244
R35 · FY2021 · GM · contact PI
Maximizing Antibody Drug Conjugate Efficacy through Multiple Mechanisms of Action$320,304
R35 · FY2020 · GM · contact PI
Maximizing Antibody Drug Conjugate Efficacy through Multiple Mechanisms of Action$326,979
R35 · FY2019 · GM · contact PI
Self-administration of Near-Infrared Fluorescent Molecular Imaging Probes for Non-Invasive Early Detection and Treatment Monitoring of Rheumatoid Arthritis$153,356
R21 · FY2019 · AR · contact PI
Maximizing Antibody Drug Conjugate Efficacy through Multiple Mechanisms of Action$349,238
R35 · FY2018 · GM · contact PI
Self-administration of Near-Infrared Fluorescent Molecular Imaging Probes for Non-Invasive Early Detection and Treatment Monitoring of Rheumatoid Arthritis$187,785
R21 · FY2018 · AR · contact PI
Whole Body Imaging of Beta Cell Mass in Diabetes$160,164
K01 · FY2014 · DK · contact PI
Whole Body Imaging of Beta Cell Mass in Diabetes$160,164
K01 · FY2013 · DK · contact PI
Whole Body Imaging of Beta Cell Mass in Diabetes$160,164
K01 · FY2012 · DK · contact PI
Whole Body Imaging of Beta Cell Mass in Diabetes$160,164
K01 · FY2011 · DK · contact PI